San Carlos, CA, United States of America

Gregory D Plowman

USPTO Granted Patents = 44 (Patent Applications = 15)

CIPO Patents = 2 (Patent Applications = 15)

EPO Patents = 4 (Patent Applications = 10)

Average Co-Inventor Count = 2.9

ph-index = 12

Forward Citations = 549(Granted Patents)

Location History:

Seattle, WA (US) (1992 - 1999)
San Carlos, CA (US) (1998 - 2016)
New York, NY (US) (2015 - 2021)

Company Filing History:

Bristol-myers Squibb Compnay

Eli Lilly and Company

10. 1 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1992-2021

Loading Chart...

Areas of Expertise:

Checkpoint Inhibitor Bispecific Antibodies

Fibroblast Growth Factor Receptor-3

Anti-Alpha5/Beta1 Antibodies

p53 Pathway Modifiers

Mylks and Branching Morphogenesis

Diagnosis of AUR1 Disorders

Polynucleotides Encoding Kinases

Human Receptor Tyrosine Kinase

Epithelins in Cell Proliferation

Vaccines Against Melanoma

Recombinant Viruses

Growth Modulating Glycoproteins

44 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11203640 - Checkpoint inhibitor bispecific antibodies (2021-12-21),

2. 9375488 - Compounds to fibroblast growth factor receptor-3 (FGFR3) and methods of treatment (2016-06-28),

3. 9284376 - Antibodies (2016-03-15),

4. 8962275 - Anti-α5β1 antibodies and uses thereof (2015-02-24),

5. 8840887 - Antibodies (2014-09-23),

6. 8771942 - SCDs as modifiers of the p53 pathway and methods of use (2014-07-08),

7. 8350010 - Anti-alpha5/beta1 antibody (2013-01-08),

8. 8268548 - MAP3Ks as modifiers of the p53 pathway and methods of use (2012-09-18),

9. 8153384 - Marks as modifiers of the p53 pathway and methods of use (2012-04-10),

10. 8124740 - Anti- α5 β1 antibodies and uses thereof (2012-02-28),

11. 8105785 - Mylks as modifiers of branching morphogenesis and methods of use (2012-01-31),

12. 7993829 - HPRP4s modifiers of the p53 pathway and methods of use (2011-08-09),

13. 7973138 - Antibodies (2011-07-05),

14. 7119174 - Diagnosis and treatment of AUR1 and/or AUR2 related disorders (2006-10-10),

15. 7115710 - Diagnosis and treatment of PTP related disorders (2006-10-03),

Title: Gregory D Plowman: Pioneering Inventor from San Carlos

Introduction: Gregory D Plowman is a renowned inventor hailing from San Carlos, California. His innovative spirit and dedication to pushing the boundaries of technology have led to groundbreaking inventions in various fields.

Latest Patents: Gregory D Plowman holds several patents in the areas of renewable energy, artificial intelligence, and medical devices. His most recent patents focus on sustainable energy solutions and cutting-edge healthcare technologies.

Career Highlights: With a career spanning over two decades, Gregory D Plowman has worked for leading tech companies, research institutions, and universities. He has been instrumental in developing disruptive technologies that have revolutionized the way we live and work.

Collaborations: Throughout his career, Gregory D Plowman has collaborated with top engineers, scientists, and researchers to bring his inventions to life. His collaborative efforts have resulted in successful products and solutions that have had a significant impact on society.

Conclusion: Gregory D Plowman's passion for innovation and his relentless pursuit of excellence have established him as a trailblazer in the world of technology. His contributions to various industries continue to inspire the next generation of inventors and innovators.

This text is generated by artificial intelligence and may not be accurate.